Clinical Trials Logo

Clinical Trial Summary

This trial is a multi-center phase III clinical trial. The purpose of this trial is to explore whether concurrent chemoradiotherapy is not inferior to induction chemotherapy combined with concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05062005
Study type Interventional
Source First Affiliated Hospital, Sun Yat-Sen University
Contact Shuang Wu, PHD
Phone +862087755766
Email [email protected]
Status Recruiting
Phase Phase 3
Start date September 22, 2021
Completion date August 31, 2027

See also
  Status Clinical Trial Phase
Completed NCT01462474 - Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma Phase 1
Recruiting NCT03574324 - TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC Phase 3
Not yet recruiting NCT04910347 - A Phase 2, Open-label Trial of Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma Phase 2
Recruiting NCT03604965 - GP Induction Chemotherapy us TPF Adjuvant Chemotherapy Combined With DDP Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC Phase 3
Recruiting NCT03015727 - Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma Phase 3